As previous reports, abundant Treg cell infiltration into tumors is associated with poor clinical outcomes in various types of cancers, including colorectal cancers (34), breast cancer (35), etc. Surprisingly, the role of Treg cells is controversial in ECs, in which Foxp3+ T cell infiltration indicated a better prognosis. The gene discussed is FOXP3; the disease is breast cancer.